The escalating demands of academic productivity, clinical responsibilities, and research expectations in oral and maxillofacial surgery (OMFS) have quietly given rise to a controversial practice: ghost-writing. As clinicians strive to balance intensive surgical workloads with scholarly output, the task of manuscript preparation is increasingly delegated to uncredited contributors—ranging from junior researchers and postgraduate students to professional medical writers. This trend raises a fundamental question: is ghost-writing a legitimate extension of collaborative effort, or an ethical transgression that undermines the credibility of academic authorship?
Ghost-writing occupies a grey ethical space. On one hand, it serves as a pragmatic solution for time-constrained surgeons, enabling them to share valuable clinical experiences and research findings that might otherwise remain unpublished. It also supports linguistic precision, coherent structuring, and adherence to journal guidelines—particularly beneficial for non-native English-speaking authors. When such assistance is transparently acknowledged through appropriate authorship or contributorship, these collaborations can enhance the quality and accessibility of medical literature without compromising academic integrity.
However, the core issue lies not in who drafts the manuscript, but in who is held accountable for its content. Crediting individuals as authors without substantial intellectual or technical contributions dilutes the meaning of authorship. According to the International Committee of Medical Journal Editors (ICMJE), authorship requires significant involvement in the conception or design of the work, drafting or critical revision, final approval of the version to be published, and accountability for all aspects of the manuscript.
In reality, these criteria are often bypassed. A study in PLoS Medicine revealed that 11% of articles across six leading medical journals exhibited evidence of ghost authorship, while 19% of industry-sponsored studies involved unacknowledged professional writers.
In surgical research—where published findings can directly shape clinical decisions—such misrepresentation can have serious consequences. Moreover, ghost-writing may obscure conflicts of interest, particularly when driven by pharmaceutical or medical device companies. The article by the World Association of Medical Editors suggests that ghost-writing initiated by commercial entities is a serious threat to the integrity of the scientific record and public trust. They advocate for a multifaceted solution: clear disclosure requirements, rigorous editorial scrutiny, and collective accountability involving all parties, not just the nominal authors.
These concerns prompt important questions: should journals require comprehensive contributorship disclosures and mandatory transparency declarations for all submissions? Should editorial boards implement stricter checks on manuscript provenance? Or should ghost-writing, akin to professional editing, be accepted as a practical tool—provided it is conducted with full transparency?
As members of the OMFS community, we must reflect: is ghost-writing a necessary scaffold that amplifies overburdened clinical voices, or a fissure in the foundation of academic integrity? The answer may not be binary—but the conversation is long overdue.
